Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Senti Biosciences (SNTI) Treasury Shares (2022 - 2025)

Senti Biosciences has reported Treasury Shares over the past 4 years, most recently at $1.1 million for Q4 2025.

  • Quarterly results put Treasury Shares at $1.1 million for Q4 2025, up 1852.79% from a year ago — trailing twelve months through Dec 2025 was $1.1 million (up 1852.79% YoY), and the annual figure for FY2025 was $1.1 million, up 1852.79%.
  • Treasury Shares for Q4 2025 was $1.1 million at Senti Biosciences, up from $56423.0 in the prior quarter.
  • Over the last five years, Treasury Shares for SNTI hit a ceiling of $6.8 million in Q2 2022 and a floor of $56423.0 in Q4 2024.
  • Median Treasury Shares over the past 4 years was $5.3 million (2023), compared with a mean of $3.6 million.
  • Biggest five-year swings in Treasury Shares: plummeted 88.79% in 2024 and later soared 1852.79% in 2025.
  • Senti Biosciences' Treasury Shares stood at $447948.0 in 2022, then rose by 12.32% to $503114.0 in 2023, then plummeted by 88.79% to $56423.0 in 2024, then soared by 1852.79% to $1.1 million in 2025.
  • The last three reported values for Treasury Shares were $1.1 million (Q4 2025), $56423.0 (Q4 2024), and $503114.0 (Q4 2023) per Business Quant data.